ArticleCancer treatment and research communications2017

Phase II Study of Dovitinib in Patients Progressing on Anti-Vascular Endothelial Growth Factor Therapy.

Thomas J Semrad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.